CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,045,776 | -41.3% | 89,459 | -32.6% | 0.06% | -39.6% |
Q2 2023 | $1,783,058 | +19.3% | 132,668 | +47.2% | 0.10% | +4.3% |
Q1 2023 | $1,494,422 | +537.2% | 90,134 | +614.8% | 0.09% | +513.3% |
Q4 2022 | $234,546 | +45.7% | 12,610 | +0.4% | 0.02% | +25.0% |
Q3 2022 | $161,000 | – | 12,555 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |